SCYNEXIS, Inc. Share Price
NASDAQ: SCYX | Micro CapSCYNEXIS, Inc. Stock Performance
Open $5.17 | Prev. Close $5.17 | Circuit Range N/A |
Day Range $4.69 - $5.17 | Year Range $0.57 - $5.50 | Volume 8,061 |
Average Traded $4.82 |
SCYNEXIS, Inc. Share Price Today
As of 12 August 2026, SCYNEXIS, Inc.'s share price is $4.84. The stock opened at $5.17, compared to its previous close of $5.17. During today's trading session, SCYNEXIS, Inc.'s share price traded between $4.69 and $5.17, with an average price of $4.93. Over the past 52 weeks, the stock has recorded a high of $5.50 and a low of $0.57. In terms of performance, SCYNEXIS, Inc.'s share price has risen by 549.66% over the last six months and is up 482.43% on a year-on-year basis.
SCYNEXIS, Inc. Share Price Chart
SCYNEXIS, Inc. Stock Fundamentals & Key Indicators
Market Cap $241.68M | PE Ratio (TTM) -28.47 | Dividend Yield N/A |
EPS (TTM) $-0.17 | Revenue (TTM) $20.60M | Return On Equity (TTM) -17.44% |
Profit Margin -41.79% | Debt to Equity 0.12 | Quarterly Earnings Growth YoY -205.95% |
SCYNEXIS, Inc. Quarterly Profit & Loss
All figures in USD
SCYNEXIS, Inc. Annual Profit & Loss
All figures in USD
About SCYNEXIS, Inc.
SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
SCYNEXIS, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.81 | $4.83 | -1.12% |
Jul 2026 | $4.13 | $4.89 | +20.62% |
Jun 2026 | $5.26 | $4.05 | +471.79% |
May 2026 | $0.94 | $0.71 | -24.01% |
Apr 2026 | $0.89 | $0.93 | +2.53% |
Mar 2026 | $0.74 | $0.91 | +22.15% |
Feb 2026 | $0.70 | $0.74 | +4.78% |
Jan 2026 | $0.63 | $0.71 | +13.94% |
Dec 2025 | $0.67 | $0.62 | -11.74% |
Nov 2025 | $0.64 | $0.71 | +7.12% |
Oct 2025 | $0.80 | $0.66 | -15.28% |
Sep 2025 | $0.81 | $0.78 | -6.26% |
SCYX Share Price FAQs
What is SCYNEXIS, Inc. share price today?
What is the 52 week high and 52 week low of SCYNEXIS, Inc. stock?
What is SCYX's market capitalisation today?
What is SCYX's net income for the last quarter?
What is the 5 year returns of SCYX?
What is the high & low stock price of SCYX today?
Can I buy SCYX shares in India?